191 related articles for article (PubMed ID: 19553342)
1. Kaposi's sarcoma-associated herpesvirus protein LANA2 disrupts PML oncogenic domains and inhibits PML-mediated transcriptional repression of the survivin gene.
Marcos-Villar L; Lopitz-Otsoa F; Gallego P; Muñoz-Fontela C; González-Santamaría J; Campagna M; Shou-Jiang G; Rodriguez MS; Rivas C
J Virol; 2009 Sep; 83(17):8849-58. PubMed ID: 19553342
[TBL] [Abstract][Full Text] [Related]
2. Covalent modification by SUMO is required for efficient disruption of PML oncogenic domains by Kaposi's sarcoma-associated herpesvirus latent protein LANA2.
Marcos-Villar L; Campagna M; Lopitz-Otsoa F; Gallego P; González-Santamaría J; González D; Rodriguez MS; Rivas C
J Gen Virol; 2011 Jan; 92(Pt 1):188-94. PubMed ID: 20881090
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53.
Rivas C; Thlick AE; Parravicini C; Moore PS; Chang Y
J Virol; 2001 Jan; 75(1):429-38. PubMed ID: 11119611
[TBL] [Abstract][Full Text] [Related]
4. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
5. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation.
Lu J; Verma SC; Murakami M; Cai Q; Kumar P; Xiao B; Robertson ES
J Virol; 2009 Jul; 83(14):7129-41. PubMed ID: 19439469
[TBL] [Abstract][Full Text] [Related]
6. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
7. Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression.
Xu Y; Ahn JH; Cheng M; apRhys CM; Chiou CJ; Zong J; Matunis MJ; Hayward GS
J Virol; 2001 Nov; 75(22):10683-95. PubMed ID: 11602710
[TBL] [Abstract][Full Text] [Related]
8. Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
Chang PJ; Chen LW; Chen LY; Hung CH; Shih YJ; Wang SS
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701396
[TBL] [Abstract][Full Text] [Related]
9. KSHV latent protein LANA2 inhibits sumo2 modification of p53.
Laura MV; de la Cruz-Herrera CF; Ferreirós A; Baz-Martínez M; Lang V; Vidal A; Muñoz-Fontela C; Rodríguez MS; Collado M; Rivas C
Cell Cycle; 2015; 14(2):277-82. PubMed ID: 25607652
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma.
Manzano M; Günther T; Ju H; Nicholas J; Bartom ET; Grundhoff A; Gottwein E
mBio; 2020 Aug; 11(4):. PubMed ID: 32843547
[TBL] [Abstract][Full Text] [Related]
11. Origin-independent assembly of Kaposi's sarcoma-associated herpesvirus DNA replication compartments in transient cotransfection assays and association with the ORF-K8 protein and cellular PML.
Wu FY; Ahn JH; Alcendor DJ; Jang WJ; Xiao J; Hayward SD; Hayward GS
J Virol; 2001 Feb; 75(3):1487-506. PubMed ID: 11152521
[TBL] [Abstract][Full Text] [Related]
12. Induction of paclitaxel resistance by the Kaposi's sarcoma-associated herpesvirus latent protein LANA2.
Muñoz-Fontela C; Marcos-Villar L; Hernandez F; Gallego P; Rodriguez E; Arroyo J; Gao SJ; Avila J; Rivas C
J Virol; 2008 Feb; 82(3):1518-25. PubMed ID: 18032494
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the bipartite nuclear localization signal of protein LANA2 from Kaposi's sarcoma-associated herpesvirus.
Muñoz-Fontela C; Rodríguez E; Nombela C; Arroyo J; Rivas C
Biochem J; 2003 Sep; 374(Pt 2):545-50. PubMed ID: 12767255
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7.
Kim YJ; Kim Y; Kumar A; Kim CW; Toth Z; Cho NH; Lee HR
PLoS Pathog; 2021 Jan; 17(1):e1009179. PubMed ID: 33471866
[TBL] [Abstract][Full Text] [Related]
15. Ability of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cells.
Lee HR; Kim DJ; Lee JM; Choi CY; Ahn BY; Hayward GS; Ahn JH
J Virol; 2004 Jun; 78(12):6527-42. PubMed ID: 15163746
[TBL] [Abstract][Full Text] [Related]
16. The latency protein LANA2 from Kaposi's sarcoma-associated herpesvirus inhibits apoptosis induced by dsRNA-activated protein kinase but not RNase L activation.
Esteban M; García MA; Domingo-Gil E; Arroyo J; Nombela C; Rivas C
J Gen Virol; 2003 Jun; 84(Pt 6):1463-1470. PubMed ID: 12771415
[TBL] [Abstract][Full Text] [Related]
17. Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells.
Long C; Guo W; Zhou H; Wang J; Wang H; Sun X
Int J Oncol; 2016 Apr; 48(4):1519-30. PubMed ID: 26821279
[TBL] [Abstract][Full Text] [Related]
18. Importance of Promyelocytic Leukema Protein (PML) for Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
Hossain MG; Ohsaki E; Honda T; Ueda K
Front Microbiol; 2018; 9():2324. PubMed ID: 30349510
[TBL] [Abstract][Full Text] [Related]
19. Screening of the Human Kinome Identifies MSK1/2-CREB1 as an Essential Pathway Mediating Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication during Primary Infection.
Cheng F; Sawant TV; Lan K; Lu C; Jung JU; Gao SJ
J Virol; 2015 Sep; 89(18):9262-80. PubMed ID: 26109721
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
